新潟市民病院は、新潟県新潟市中央区にある医療機関。新潟市が運営する地方公営企業の一つである。

During the past decade, Niigata City General Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Niigata City General Hospital" #1 sponsor was "Daiichi Sankyo Co., Ltd." with 2 trials, followed by "AbbVie" with 1 trials sponsored, "Bayer" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Joseph Broderick, MD" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Niigata City General Hospital" #1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator and "Novo Nordisk A/S" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Niigata City General Hospital" are "Acute Ischemic Stroke" (1 trials), "Anemia" (1 trials), "Ankylosing Spondylitis" (1 trials), "Central Neuropathic Pain" (1 trials) and "Hereditary Angioedema (HAE)" (1 trials). Many other conditions were trialed in "Niigata City General Hospital" in a lesser frequency.

Most popular intervention types in "Niigata City General Hospital" are "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "DS1040b" (1 trials), "Icatibant" (1 trials), "Mirogabalin" (1 trials) and "Molidustat (BAY85-3934)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Niigata City General Hospital" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Niigata City General Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Niigata City General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Niigata City General Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".